CASE REPORT Year : 2023  |  Volume : 38  |  Issue : 1  |  Page : 53-55  

Askin tumor - Presenting as a case of paraparesis: A rare clinical entity. Case report and findings on 18F-Fluorodeoxyglucose-positron emission tomography/computed tomography

Kalpa Jyoti Das1, Akash Kumar2, Sneha Prakash1, Abhinav Singhal1
1 Department of Nuclear Medicine, National Cancer Institute (All India Institute of Medical Sciences-New Delhi), Jhajjar, Haryana, India
2 Department of Medical Oncology, National Cancer Institute (All India Institute of Medical Sciences-New Delhi), Jhajjar, Haryana, India

Date of Submission06-Aug-2022Date of Acceptance07-Sep-2022Date of Web Publication24-Feb-2023

Correspondence Address:
Dr. Kalpa Jyoti Das
Department of Nuclear Medicine, National Cancer Institute (All India Institute of Medical Sciences-New Delhi), Jhajjar, Haryana
India

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/ijnm.ijnm_139_22

   Abstract 

Askin tumors are rare malignant neoplasms located in the thoracopulmonary region and mainly occur in children and adolescents. In this report, we describe a case of histologically proven Askin's tumor in a 24-year-old male. The patient was admitted with a history of 3-month lower back pain and with a rare presentation of paraparesis.

Keywords: Askin tumor, Ewing sarcoma family of tumors, fluorodeoxyglucose, fluorodeoxyglucose positron emission tomography/computed tomography, paraparesis, peripheral primitive neuro-ectodermal tumor

How to cite this article:
Das KJ, Kumar A, Prakash S, Singhal A. Askin tumor - Presenting as a case of paraparesis: A rare clinical entity. Case report and findings on 18F-Fluorodeoxyglucose-positron emission tomography/computed tomography. Indian J Nucl Med 2023;38:53-5
How to cite this URL:
Das KJ, Kumar A, Prakash S, Singhal A. Askin tumor - Presenting as a case of paraparesis: A rare clinical entity. Case report and findings on 18F-Fluorodeoxyglucose-positron emission tomography/computed tomography. Indian J Nucl Med [serial online] 2023 [cited 2023 Feb 25];38:53-5. Available from: https://www.ijnm.in/text.asp?2023/38/1/53/370426    Introduction 

Askin-Rosai tumor (AT) is a rare primitive neuroectodermal tumor (PNET) developing from the soft tissues of the thoracopulmonary region, primarily occurs in adolescents and young adults aged between 10 and 30 years.[1] It belongs to the Ewing's sarcoma family of tumors sharing the same karyotype abnormality with translocation involving chromosomes 11 and 22.[2] The most common clinical presentation is a rapidly growing palpable mass overlying the chest wall.[3] Other common clinical presentations include pleural effusion, chest pain, prolonged fever, cough, dyspnea, and hemoptysis. AT is usually localized to the site of origin in the thoracic area at the time of presentation, although the tumor has a tendency to metastasize to the regional and distant sites.[3] The common sites of metastases include the lung, bone, bone marrow, and liver. Askin tumor presenting as compressive myelopathy is extremely rare. Herein, we describe a case of Askin tumor involving the spine with a rare presentation of paraparesis.

   Case Report 

A 24-year-old male with no comorbidities presented to the outpatient department with complaints of gradually progressive swelling in the upper back and weakness in bilateral lower limb for 3 months. At the time of presentation, the patient was paraplegic with 20%–40% sensory loss below D8 vertebral level bilaterally and with urinary and bladder incontinence. Neurological examination revealed power grading 5/5 in both upper limbs and 0/5 in bilateral lower limbs. Deep-tendon reflex was exaggerated in both the lower limbs. The patient was completely bed ridden, bladder catheterized with Grade 3 bed sores over the buttock region. Physical examination revealed 4 cm × 6 cm firm lesion in the back region. His magnetic resonance imaging of dorsal spin confirmed the presence of a well-defined multilobulated mass lesion epicentered in the right posterior chest wall extending from D5 to D10 vertebral level with invasion into the right thoracic cavity causing passive atelectasis of the underlying lung. The lesion was found to invade the right neural foramina at D6-D8 vertebral level with compression and displacement of spinal cord to the left side. It showing altered signal intensity appearing hyperintense on T2W1. Histopathological examination of tumor from the paraspinal mass showed features of malignant round cell tumor with nuclear immunoreactivity of NKX 2.2. The patient was started on prephase therapy. Post prephase therapy he was referred to the nuclear medicine department for a positron emission tomography/computed tomography (PET/CT) scan for work-up. PET/CT imaging was performed after intravenous injection of 10 mCi 18F-fluorodeoxyglucose (18F-FDG). PET/CT revealed a metabolically active heterogeneously enhancing soft-tissue density mass lesion with areas of necrosis and calcifications in thoraco-pulmonary region involving the right posterior chest wall with destruction of right 6th–8th ribs and adjacent vertebra with infiltration into the spinal canal abutting and compressing the cord. Maximum calculated standardized uptake value (SUVmax) of the lesion was 4.36 [Figure 1]. There was moderate right pleural effusion. Few metabolically active subcentimetric right extra pleural deposits and metabolically active bilateral supraclavicular, right paratracheal, subcarinal and right retrocrural lymph nodes were also noted and deemed to be metastatic.

Figure 1: Axial fused PET/CT (a) and CT (b) and coronal fused PET/CT (c) and CT (d) images in a 24-year-old boy with lower back pain revealed a FDG avid heterogeneously enhancing thoracopulomary mass lesion in the right paravertebral region with areas of necrosis and calcifications infiltrating into the right thoracic cavity and into the right side of spinal canal abutting and compressing the cord. The adjacent ribs and thoracic vertebrae show destruction due to tumor infiltration. PET/CT: Positron emission tomography/computed tomography, FDG: Fluorodeoxyglucose

Click here to view

   Discussion 

PNETs can arise either form the central nervous system PNET or from periphery-PNET.[4] Peripheral PNETs most commonly involve the chest wall pleura, pericardium, and soft tissue. PNETs of the chest wall were originally reported by Askin et al. in 1979 in 20 children;[1] since then, PNETs that occur within the thoracopulmonary region are named as Askin's tumor. It is a rare malignant neoplasm, locally invasive in nature and prone to destroying bone (ribs and scapula) and spreading to lymph nodes, adrenals, and liver. Askin tumor infiltrating the spinal cord and presenting as a case of compressive myelopathy is rare. In a study of 104 patients of Askin tumor by Lashkar et al., asymptomatic swelling (43%) was the most common presenting symptom followed by pleural effusion. Lymphadenopathy was observed in 10.9% of cases and 25% of patient presented with distant metastases. None of the cases presented with compressive myelopathy.[5] In another case series of 11 patients by Ke Zhang et al., the most common clinical symptoms included fever, cough, chest pain, and suffocation.[6] In a review of the literature on peripheral PNET of the thoracic region, Anjankar et al. reported 19 such cases with epidural mass in adults, with a female: male ratio of 1:1.7 and the average age of presentation at 30 years.[7] Presenting symptoms were back pain in all patients, followed by weakness in limb (70%), sensory loss (35%) and the diagnostic delay was approximately 4.5 months. There are not many case reports describing Askin tumor 18F-FDG PET/CT results. Xia et al. evaluated 6 patients of Askin tumor with 18F-FDG PET and observed that the lesion SUVmax varied from 4.0 to 18.6.[8] However, Kara Gedik et al. reported a SUVmax of 4.3 in their case report of 73-year-old male with Askin tumor.[9] In our case, the age at presentation was 24 year, patient reported with signs and symptoms of compressive myelopathy which is a rare presentation in AT. 18F-FDG PET/CT helped in characterization of metabolic activity of the tumor and in the detection of distant metastases. The metabolic activity of the tumor in our case was low (SUVma × 4.6) in concordance with Gedik et al. Metastatic nodes were observed in supraclavicular, mediastinal, and retrocural region. Supraclavicular and retrocural metastatic nodes were also observed by Xia et al. in 2 of their 6 patients undergoing FDG-PET scan. Winer-Muram et al. reported mediastinal lymph node metastases in 2 out of 8 Askin tumors,[10] while Sabate et al. reported mediastinal lymph node metastases in 1 out of 8 Askin tumors.[11]

The prognosis of AT is very poor. Because of rarity of the neoplasm, there are no consensus guideline. The treatment of Askin tumour is multidisciplinary including surgery, radiotherapy and chemotherapy aimed to control local disease and distant metastases.

   Conclusion 

This case emphasizes the fact that although Askin's tumor with compressive myelopathy is rare, it should be considered as one etiologic possibility in a young adult presenting as a case of paraplegia.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient (s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initial s will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 

   References 
1.Askin FB, Rosai J, Sibley RK, Dehner LP, McAlister WH. Malignant small cell tumor of the thoracopulmonary region in childhood: A distinctive clinicopathologic entity of uncertain histogenesis. Cancer 1979;43:2438-51.  
    2.Murphey MD, Senchak LT, Mambalam PK, Logie CI, Klassen-Fischer MK, Kransdorf MJ. From the radiologic pathology archives: Ewing sarcoma family of tumors: Radiologic-pathologic correlation. Radiographics 2013;33:803-31.  
    3.Abbas AA, Almaghraby HQ. The askin-rosai tumor: A clinicopathological review. Pediatr Surg 2020;5:14.  
    4.D'siar DL, Ghosh S, Siddique SI, Ghosh A. A rare case of dorsal spine primitive neuroectodermal tumor (P.N.E.T) presenting with features of Pott's spine. Int J Surg Sci 2021;5:155-7.  
    5.Laskar S, Nair C, Mallik S, Bahl G, Pai S, Shet T, et al. Prognostic factors and outcome in Askin-Rosai tumor: A review of 104 patients. Int J Radiat Oncol Biol Phys 2011;79:202-7.  
    6.Zhang KE, Lu R, Zhang P, Shen S, Li X. Askin's tumor: 11 cases and a review of the literature. Oncol Lett 2016;11:253-6.  
    7.Anjankar S. Askin's tumor in adult: A rare clinical entity. J Datta Meghe Inst Med Sci Univ 2018 Jan 1;13:54.  
    8.Xia T, Guan Y, Chen Y, Li J. Askin tumor: CT and FDG-PET/CT imaging findings and follow-up. Medicine (Baltimore) 2014;93:e42.  
    9.Kara Gedik G, Sari O, Altinok T, Tavli L, Kaya B, Ozcan Kara P. Askin's tumor in an adult: Case report and findings on 18F-FDG PET/CT. Case Rep Med 2009;2009:517329.  
    10.Winer-Muram HT, Kauffman WM, Gronemeyer SA, Jennings SG. Primitive neuroectodermal tumors of the chest wall (Askin tumors): CT and MR findings. AJR Am J Roentgenol 1993;161:265-8.  
    11.Sabaté JM, Franquet T, Parellada JA, Monill JM, Oliva E. Malignant neuroectodermal tumour of the chest wall (Askin tumour): CT and MR findings in eight patients. Clin Radiol 1994;49:634-8.  
    
  [Figure 1]